GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (OTCPK:NRXBF) » Definitions » Issuance of Stock

NRXBF (NurExone Biologic) Issuance of Stock : $1.33 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NurExone Biologic Issuance of Stock?

NurExone Biologic's Issuance of Stock for the three months ended in Sep. 2024 was $0.76 Mil.

NurExone Biologic's Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2024 was $1.33 Mil.

NurExone Biologic Issuance of Stock Historical Data

The historical data trend for NurExone Biologic's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NurExone Biologic Issuance of Stock Chart

NurExone Biologic Annual Data
Trend Dec21 Dec22 Dec23
Issuance of Stock
2.23 2.33 0.74

NurExone Biologic Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.57 - 0.76

NurExone Biologic Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NurExone Biologic Issuance of Stock Related Terms

Thank you for viewing the detailed overview of NurExone Biologic's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

NurExone Biologic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (OTCPK:NRXBF) » Definitions » Issuance of Stock
Comparable Companies
NEOE:BMND XCNQ:COOL XCNQ:PHRM TSX:RVX TSX:MDNA XCNQ:MDMA XCNQ:ASEP TSXV:QPT XCNQ:TELI TSX:AEZS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
J90:Germany NRX:Canada
Address
1 Adelaide St. East, Suite 801, Toronto, ON, CAN, M5C 2V9
Website
https://www.nurexone.com
NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.